9 results on '"Dariusz M. Lebensztejn"'
Search Results
2. First genome-wide association study of esophageal atresia identifies three genetic risk loci at CTNNA3, FOXF1/FOXC2/FOXL1, and HNF1B
- Author
-
Jan Gehlen, Ann-Sophie Giel, Ricarda Köllges, Stephan L. Haas, Rong Zhang, Jiri Trcka, Ayse Ö. Sungur, Florian Renziehausen, Dorothea Bornholdt, Daphne Jung, Paul D. Hoyer, Agneta Nordenskjöld, Dick Tibboel, John Vlot, Manon C.W. Spaander, Robert Smigiel, Dariusz Patkowski, Nel Roeleveld, Iris ALM. van Rooij, Ivo de Blaauw, Alice Hölscher, Marcus Pauly, Andreas Leutner, Joerg Fuchs, Joel Niethammer, Maria-Theodora Melissari, Ekkehart Jenetzky, Nadine Zwink, Holger Thiele, Alina Christine Hilger, Timo Hess, Jessica Trautmann, Matthias Marks, Martin Baumgarten, Gaby Bläss, Mikael Landén, Bengt Fundin, Cynthia M. Bulik, Tracie Pennimpede, Michael Ludwig, Kerstin U. Ludwig, Elisabeth Mangold, Stefanie Heilmann-Heimbach, Susanne Moebus, Bernhard G. Herrmann, Kristina Alsabeah, Carmen M. Burgos, Helene E. Lilja, Sahar Azodi, Pernilla Stenström, Einar Arnbjörnsson, Barbora Frybova, Dariusz M. Lebensztejn, Wojciech Debek, Elwira Kolodziejczyk, Katarzyna Kozera, Jaroslaw Kierkus, Piotr Kaliciński, Marek Stefanowicz, Anna Socha-Banasiak, Michal Kolejwa, Anna Piaseczna-Piotrowska, Elzbieta Czkwianianc, Markus M. Nöthen, Phillip Grote, Michal Rygl, Konrad Reinshagen, Nicole Spychalski, Barbara Ludwikowski, Jochen Hubertus, Andreas Heydweiller, Benno Ure, Oliver J. Muensterer, Ophelia Aubert, Jan-Hendrik Gosemann, Martin Lacher, Petra Degenhardt, Thomas M. Boemers, Anna Mokrowiecka, Ewa Małecka-Panas, Markus Wöhr, Michael Knapp, Guido Seitz, Annelies de Klein, Grzegorz Oracz, Erwin Brosens, Heiko Reutter, and Johannes Schumacher
- Subjects
genome-wide association study (GWAS) ,esophageal atresia (EA) ,multifactorial diseases ,CTNNA3 ,FOXF1/FOXC2/FOXL1 ,HNF1B ,Genetics ,QH426-470 - Abstract
Summary: Esophageal atresia with or without tracheoesophageal fistula (EA/TEF) is the most common congenital malformation of the upper digestive tract. This study represents the first genome-wide association study (GWAS) to identify risk loci for EA/TEF. We used a European case-control sample comprising 764 EA/TEF patients and 5,778 controls and observed genome-wide significant associations at three loci. On chromosome 10q21 within the gene CTNNA3 (p = 2.11 × 10−8; odds ratio [OR] = 3.94; 95% confidence interval [CI], 3.10–5.00), on chromosome 16q24 next to the FOX gene cluster (p = 2.25 × 10−10; OR = 1.47; 95% CI, 1.38–1.55) and on chromosome 17q12 next to the gene HNF1B (p = 3.35 × 10−16; OR = 1.75; 95% CI, 1.64–1.87). We next carried out an esophageal/tracheal transcriptome profiling in rat embryos at four selected embryonic time points. Based on these data and on already published data, the implicated genes at all three GWAS loci are promising candidates for EA/TEF development. We also analyzed the genetic EA/TEF architecture beyond the single marker level, which revealed an estimated single-nucleotide polymorphism (SNP)-based heritability of around 37% ± 14% standard deviation. In addition, we examined the polygenicity of EA/TEF and found that EA/TEF is less polygenic than other complex genetic diseases. In conclusion, the results of our study contribute to a better understanding on the underlying genetic architecture of ET/TEF with the identification of three risk loci and candidate genes.
- Published
- 2022
- Full Text
- View/download PDF
3. Liver sinusoidal endothelial cells in morphogenesis of pediatric autoimmune hepatitis. Ultrastructural characteristics – a novel report
- Author
-
Joanna M. Łotowska, Maria E. Sobaniec-Łotowska, Piotr Sobaniec, and Dariusz M. Lebensztejn
- Subjects
liver sinusoidal endothelial cells ,nonparenchymal hepatic cells ,pediatric autoimmune hepatitis ,pretreatment liver oligobiopsy material ,ultrastructure ,Medicine - Abstract
The pathogenesis of autoimmune hepatitis (AIH) is poorly understood. Up to now, little is known of the involvement of liver sinusoidal endothelial cells (LSECs), accounting for approximately 40% of nonparenchymal hepatic cells, in AIH morphogenesis in pediatric patients. The study objective was ultrastructural analysis of LSECs from pretreatment biopsies of 19 children, aged 4-17 years (14 girls), with clinically and histologically diagnosed AIH. Our study is the first to describe alterations in LSECs, from swelling to necrosis, demonstrating their important role in the morphogenesis and progression of pediatric AIH. Frequently damage to LSECs coexisted with significantly activated Kupffer cells, fibrogenesis and fibrosis, but not cirrhosis, accompanied by the appearance of transitional hepatic stellate cells. Interestingly, even though in half of the AIH children the sinusoidal vessels were found to undergo transformation of discontinuous into continuous endothelium showing features of defenestration, the true basement membrane did not form underneath. The fact that the basement membrane is not formed, even when LSECs are markedly damaged, may seem to indicate some regenerative capacities of these cells and lesion reversibility.
- Published
- 2019
- Full Text
- View/download PDF
4. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease
- Author
-
Natalia Wasilewska, Anna Bobrus-Chociej, Ewa Harasim-Symbor, Eugeniusz Tarasów, Małgorzata Wojtkowska, Adrian Chabowski, and Dariusz M. Lebensztejn
- Subjects
Obesity ,NAFLD ,Ceramides ,Fatty liver ,Magnetic resonance proton spectroscopy ,Nutritional diseases. Deficiency diseases ,RC620-627 - Abstract
Abstract Background Hepatic lipid accumulation is closely related to the development of insulin resistance, which is regarded as one of the most significant risk factors of nonalcoholic fatty liver disease (NAFLD). Although the exact molecular pathway leading to impaired insulin signaling has not been definitively established, ceramides are suspected mediators of lipid induced hepatic insulin resistance. Therefore, the aim of the study was to evaluate the serum ceramides concentration in obese children with NAFLD. Methods The prospective study included 80 obese children (aged 7–17 years, median 12 years) admitted to our Department to diagnose initially suspected liver disease. Patients with viral hepatitis (HCV, HBV, CMV), autoimmune (AIH), toxic and metabolic (Wilson’s disease, alfa-1–antitrypsin deficiency) liver diseases and celiac disease were excluded. NAFLD was diagnosed based on pediatric diagnostic criteria in obese children with liver steatosis in ultrasound (US) as well as elevated alanine transaminase (ALT) serum activity after exclusion of other major liver diseases listed before. Ultrasonography was used as a screening method and for qualitative assessment of the steatosis degree (graded according to Saverymuttu scale). Advanced steatosis was defined as a score > 1. The total intrahepatic lipid content (TILC) was assessed by magnetic resonance proton spectroscopy (1HMRS) which is the most accurate technique for assessment of ectopic fat accumulation. Fasting serum concentration of ceramides was measured in 62 children. Results NAFLD was diagnosed in 31 children. Significant, positive correlation was found between total serum concentration of ceramides and insulin (r = 0.3, p = 0.02) and HOMA-IR (r = 0.28, p = 0.03). Total ceramide concentration as well as specific fatty acid-ceramides (FA-ceramides) concentrations, namely: myristic, palmitic, palmitoleic, stearic, oleic, behenic and lignoceric were significantly higher (p = 0.004, p = 0.003, p = 0.007, p
- Published
- 2018
- Full Text
- View/download PDF
5. HIF-1 α as a Key Factor in Bile Duct Ligation-Induced Liver Fibrosis in Rats
- Author
-
Joanna Moczydlowska, Wojciech Miltyk, Adam Hermanowicz, Dariusz M. Lebensztejn, Jerzy A. Palka, and Wojciech Debek
- Subjects
liver fibrosis ,bile duct ligation, hif-1α ,Surgery ,RD1-811 - Abstract
Background: Although several studies suggested hypoxia as an important microenvironmental factor contributing to inflammation and fibrosis in chronic liver diseases, the mechanism of this process is not fully understood. We considered hypoxia inducible factor (HIF-1α) as a key transcription factor in liver fibrosis. The aim of the study was to evaluate the mechanisms of signaling pathway during bile duct ligation (BDL)-induced liver fibrosis in rats. Methods: BDL animal model of liver fibrosis was used in the study. Male Wistar rats were divided randomly into two experimental groups: sham group (n = 15), BDL group (n = 30). Hydroxyproline (Hyp) content as a marker of collagen accumulation in liver of rats subjected to BDL was evaluated according to the method described by Gerling B et al. Expression of signaling proteins [integrin β1 receptor, HIF-1α, nuclear factor kappa B (NF-κB), and transforming growth factor (TGF-β)] was evaluated applying Western-immunoblot analysis. In all experiments, the mean values for six assays ± standard deviations (SD) were calculated. The results were submitted to the statistical analysis using the Student's “t” test, accepting p < 0.05 as significant. Results: Ligation of bile ducts was found to increase Hyp content in rat liver, accompanied by increase of HIF-1α expression during 10 weeks after BDL. The Hyp level was time dependent. There was not such a difference in control group (p < 0.001). Simultaneously expression of NF-κB, TGF-β, β1-integrin receptor was significantly elevated starting from sixth week after ligation. Activity of metalloproteinases 2 and 9 in the livers were increased 1 week after surgery and remained increased until the end of the experiment. Conclusions: The mechanism of development of liver fibrosis involves activation of Matrix metalloproteinase-2 (MMP-2) and Matrix metalloproteinase-9 (MMP-9), upregulation of HIF-1α transcriptional activity and its related factors, NF-κB and TGF-β. It suggests that they may represent targets for the treatment of the disease.
- Published
- 2017
- Full Text
- View/download PDF
6. Production and Use of Recombinant Profilins Amb a 8, Art v 4, Bet v 2, and Phl p 12 for Allergenic Sensitization Studies
- Author
-
Beata Cudowska, A. Brenda Kapingidza, Magdalena Pawłowicz, Agnieszka Pampuch, Noah Hyduke, Swanandi Pote, Caleb R. Schlachter, Dariusz M. Lebensztejn, Maksymilian Chruszcz, and Krzysztof Kowal
- Subjects
recombinant allergen ,ige ,pollen-food allergy ,profilin ,Organic chemistry ,QD241-441 - Abstract
Four recombinant (r) allergens (rAmb a 8.0101, rArt v 4.0101, rBet v 2.0101, and rPhl p 12.0101) were successfully produced and used for sensitization studies. The allergens belong to the profilin family which is one of the most numerous allergen families. These four proteins represent allergens originating from pollen of weeds (rAmb a 8.0101 and rArt v 4.0101), tree (rBet v 2.0101) and grass (rPhl p 12.0101). The recombinant allergens were characterized using various biochemical and biophysical methods and tested for their ability to bind patient-derived antibodies. One hundred patients aged 2 to 50 years sensitized to pollen and plant-derived food allergens (IgE > 0.35 kU/L) were included. Sensitization to individual allergen sources and components of birch and timothy pollens was evaluated using multiparameter immunoblots. The presence of IgE to pollen-derived recombinant profilins rAmb a 8.0101, rArt v 4.0101, rBet v 2.0101, and rPhl p 12.0101 in serum was evaluated using ELISA method. The presence of IgE against pollen profilins was detected in 20 out of 100 studied patients. High correlation was seen between IgE ELISA results with individual pollen profilins. In summary, it was shown that the recombinant versions of the four allergenic profilins can be used for sensitization studies and for component-resolved allergy diagnostics.
- Published
- 2020
- Full Text
- View/download PDF
7. First genome-wide association study of esophageal atresia identifies three genetic risk loci at
- Author
-
Jan, Gehlen, Ann-Sophie, Giel, Ricarda, Köllges, Stephan L, Haas, Rong, Zhang, Jiri, Trcka, Ayse Ö, Sungur, Florian, Renziehausen, Dorothea, Bornholdt, Daphne, Jung, Paul D, Hoyer, Agneta, Nordenskjöld, Dick, Tibboel, John, Vlot, Manon C W, Spaander, Robert, Smigiel, Dariusz, Patkowski, Nel, Roeleveld, Iris Alm, van Rooij, Ivo, de Blaauw, Alice, Hölscher, Marcus, Pauly, Andreas, Leutner, Joerg, Fuchs, Joel, Niethammer, Maria-Theodora, Melissari, Ekkehart, Jenetzky, Nadine, Zwink, Holger, Thiele, Alina Christine, Hilger, Timo, Hess, Jessica, Trautmann, Matthias, Marks, Martin, Baumgarten, Gaby, Bläss, Mikael, Landén, Bengt, Fundin, Cynthia M, Bulik, Tracie, Pennimpede, Michael, Ludwig, Kerstin U, Ludwig, Elisabeth, Mangold, Stefanie, Heilmann-Heimbach, Susanne, Moebus, Bernhard G, Herrmann, Kristina, Alsabeah, Carmen M, Burgos, Helene E, Lilja, Sahar, Azodi, Pernilla, Stenström, Einar, Arnbjörnsson, Barbora, Frybova, Dariusz M, Lebensztejn, Wojciech, Debek, Elwira, Kolodziejczyk, Katarzyna, Kozera, Jaroslaw, Kierkus, Piotr, Kaliciński, Marek, Stefanowicz, Anna, Socha-Banasiak, Michal, Kolejwa, Anna, Piaseczna-Piotrowska, Elzbieta, Czkwianianc, Markus M, Nöthen, Phillip, Grote, Michal, Rygl, Konrad, Reinshagen, Nicole, Spychalski, Barbara, Ludwikowski, Jochen, Hubertus, Andreas, Heydweiller, Benno, Ure, Oliver J, Muensterer, Ophelia, Aubert, Jan-Hendrik, Gosemann, Martin, Lacher, Petra, Degenhardt, Thomas M, Boemers, Anna, Mokrowiecka, Ewa, Małecka-Panas, Markus, Wöhr, Michael, Knapp, Guido, Seitz, Annelies, de Klein, Grzegorz, Oracz, Erwin, Brosens, Heiko, Reutter, and Johannes, Schumacher
- Abstract
Esophageal atresia with or without tracheoesophageal fistula (EA/TEF) is the most common congenital malformation of the upper digestive tract. This study represents the first genome-wide association study (GWAS) to identify risk loci for EA/TEF. We used a European case-control sample comprising 764 EA/TEF patients and 5,778 controls and observed genome-wide significant associations at three loci. On chromosome 10q21 within the gene
- Published
- 2021
8. [Immunotherapy in aplastic anaemia as a cause of reactivation of hepatitis B virus-immunologic aspects]
- Author
-
Włodzimierz, Luczyński, Katarzyna, Muszyńska-Rosłan, Maryna, Krawczuk-Rybak, and Dariusz M, Lebensztejn
- Subjects
Male ,Anemia, Aplastic ,Interferon-alpha ,Antiviral Agents ,Combined Modality Therapy ,Hepatitis B, Chronic ,Antigens, CD ,Lamivudine ,Cyclosporine ,Humans ,Reverse Transcriptase Inhibitors ,Immunotherapy ,Child ,Immunosuppressive Agents - Abstract
We present history of 16-year-old boy, HBsAg carrier, treated with interferon alpha at the age of 6 because of hepatitis B (HBeAg/antyHBe seroconversion). In August 2002--admitted to Department of Pediatric Oncology due to pancytopenia--diagnosis of severe aplastic anaemia was made (bone marrow cellularity--10%). We found no relative donor for hematopoietic cells transplantation and started immunosuppresive therapy (ATG, G-CSF, methyloprednisolon, cyclosporin). Haematologic parameters were improving. At day +60 he was admitted to our Department due to the increase in aminotransferases and cyclosporin activity. He was treated with cefuroxim, acyclovir and drugs improving liver cell function, cyclosporin was stopped. Presence of HBV DNA in serum confirmed HBV reactivation--a boy received lamivudine and cyclosporin again (as a maintenance therapy of aplastic anaemia). Aminotransferase activity and haematological parameters returned to normal. This case indicates the possibility of HBV reactivation in the course of immunosuppressive therapy (e.g. after antithymocytic globulin and cyclosporin) for aplastic anaemia.
- Published
- 2006
9. Serum fibrosis markers as predictors of an antifibrotic effect of interferon alfa in children with chronic hepatitis B.
- Author
-
Dariusz M Lebensztejn, Maria E Sobaniec-Lotowska, Michael Bauer, Maciej Kaczmarski, Michael Voelker, and Detlef Schuppan
- Published
- 2005
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.